Rates of first infection following kidney transplant in the United States (Q51673340)

9 April 2018

title

Rates of first infection following kidney transplant in the United States (English)

1 reference

9 April 2018

main subject

United States of America

0 references

author name string

Jon J Snyder

1 reference

9 April 2018

Ajay K Israni

1 reference

9 April 2018

Yi Peng

1 reference

9 April 2018

Lin Zhang

1 reference

9 April 2018

Teresa A Simon

1 reference

9 April 2018

Bertram L Kasiske

1 reference

9 April 2018

language of work or name

English

0 references

publication date

19 November 2008

1 reference

9 April 2018

published in

Kidney International

1 reference

9 April 2018

volume

1 reference

9 April 2018

issue

1 reference

9 April 2018

page(s)

317-326

1 reference

9 April 2018

Hospitalizations for bacterial septicemia after renal transplantation in the united states

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Hospitalizations for fungal infections after renal transplantation in the United States

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Pulmonary infectious mortality among patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Hospitalizations for cytomegalovirus disease after renal transplantation in the United States

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Predictors and Outcomes of Candiduria in Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Nosocomial infections in renal transplant patients: risk factors and treatment implications associated with urinary tract and surgical site infections

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

The incidence and costs of sepsis and pneumonia before and after renal transplantation in the United States

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Invasive pneumococcal disease in solid organ transplant recipients--10-year prospective population surveillance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Exponentially increased risk of infectious death in older renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Infectious complications after kidney transplantation: current epidemiology and associated risk factors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Infection frequency and profile in different age groups of kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Risk factors for hospitalization for bacterial or viral infection in renal transplant recipients--an analysis of USRDS data.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Infection in organ-transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Different impacts of hepatitis B virus and hepatitis C virus on the outcome of kidney transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Hepatitis C virus infection and kidney transplantation: predictors of patient and graft survival

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Influence of hepatitis C on renal function after liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Impact of hepatitis C virus on renal transplantation: association with poor survival.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Emerging issues in hepatitis C virus-positive liver and kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Is hepatitis C more aggressive in renal transplant patients than in patients with end-stage renal disease?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Impact of hepatitis C virus infection on patient and graft survival in kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

De novo glomerulonephritis in renal allografts with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Impaired renal allograft, but not patient survival, in patients with antibodies to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

HCV antibody positivity significantly affects renal allograft survival

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Hepatitis C and renal transplantation in the era of modern immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Diabetes mellitus after kidney transplantation in the United States

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Donor hepatitis C seropositivity: clinical correlates and effect on early graft and patient survival in adult cadaveric kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Infectious complications in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Epidemiology of Urinary Infections in Renal Transplant Recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Effect of antiviral chemoprophylaxis on adverse clinical outcomes associated with cytomegalovirus after liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Enhanced (cytomegalovirus) viral replication after transplantation for fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Rejection treatment and cytomegalovirus infection as risk factors for Pneumocystis carinii pneumonia in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Cancer after kidney transplantation in the United States

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

A new name (Pneumocystis jiroveci) for Pneumocystis from humans

1 reference

https://api.crossref.org/works/10.1038%2FKI.2008.580

7 January 2021

Identifiers

DOI

10.1038/KI.2008.580

1 reference

9 April 2018

Dimensions Publication ID

1032573018

0 references

1 reference

9 April 2018